Bleximenib (J&J-75276617)
AML Global MOA Video





Contents
Market-Leading Visual Storytellers
-
Build your own system
-
Chapterized scipts
-
Popular packages
-
One-pager
Flexible & Modular Approach for Blexi
-
Narrative development
-
Pricing options
Strategic Services for Blexi
-
Team structure
-
Partnering
Team Structure
& Partnering
-
Bespoke Animation Capabilities
-
Additional capes, work samples, testimonials (Appendix)

Leadership Team


Sean
Rooney, PhD
Chief Medical Strategy
Yury
Stefanov, PhD
Chief Science Officer at MoA, MoD animation Department
Ivan
Konstantinov, MSc
CEO, Founder,
Art Director


Michael
Russo
Strategic Partnerships
—

17+ years agency experience across multiple disciplines
—
30+ years life science communications
PhD in Immunology from Harvard University
Jane Coffin Childs Postdoctoral Fellowship at Rockefeller University
Former Managing Partner within HCG (an Omnicom company) and Chief Science Officer at VML Health (a WPP company)
Dean of OncU (Omnicom)
and faculty at Oncology Academy (WPP)
—
—
—
—
Health tech startups, global agency networks
Onc/hem global launches, IMIDs, PD-1, etc.
Software & technology
solutions for Pharma
B.S. Marketing & Advertising Emerson College
Omnicom executive leadership program: Harvard led
—
—
—
—
—
—
15+ years life science communications across
multiple disciplines
—
PhD molecular biology
—
300+ animation developed
for TOP pharma companies
—
49 awards received, including two from Science and National Science Foundation
—
16+ years life science communications across
multiple disciplines
—
20+ years digital communications
—
MSc molecular biology
—
Professional Biomedical Illustrator (AMI)
—
49 awards received, including two from Science and National Science Foundation
We support Biotechs and Pharma
at every stage of the life cycle

PRECLINICAL
DEVELOPMENT
CLINICAL DEVELOPMENT
Phase 1 | Phase 2 | Phase 3
LAUNCH /
POST LAUNCH
BRAND MATURITY
Phase 4

Trusted by Top-20 Pharma and 100+ small and medium Biotechs


High Science. Tech-Enabled
Strategy
Content
Digital + Social
Most Tech-enabled
We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent





-
MoD/MoA animation
and illustration -
Corporate & IR decks
-
Field content
-
Congress booth programs
-
Websites
-
75% of routine steps are automated using proprietary software and machine learning.
-
The most efficient production pipeline with 3x faster delivery.
-
Data-driven feedback loop optimization for every asset.
-
Live strategy workshops
-
Scientific communications
platform (ScP), lexicon -
Content optimization
and channel planning
-
Microcontent planning
and development:
-
Custom apps
-
Veeva-trained staff
-
Animated data
-
15-second videos
-
Visual digests
All fueled by the most advanced production pipeline in the industry

15 years in hematology & oncology space
50+


Collaboration with EHA
-
Clonal hematopoiesis (CHIP): mechanisms and consequences
-
The leukemic Bone Marrow niche and pathogenesis of AML
-
BCL2: genetic alteration and role in lymphoid malignancies
-
Mechanisms of action: CAR-T cells
-
Mechanisms of action: Bispecific Abs
-
Mechanisms of action: small molecules inhibitors
-
The role of epigenetic mechanisms in hematological malignancies

-
Techniques: NGS (TIF: PH)
-
Techniques: qPCR (TIF: PH)
-
Techniques: single cell genetics (TIF: pH)
-
Von Willebrand factor structure and defects
-
AI in hematology: AI-based digital morph. analysis
-
Synthetic patients in clinical trials
-
RBCs: Hb linking and releasing O2
Selected Animations:


Collaboration with Scientific Publishers, Foundations and Patient organizations



10 Universities:

5 Publishers:
15+ Patient Organizations
and Foundations
Market-Leading
Visual Storytellers




6 animation types
and 20 subtypes for every need — audience, company stage and budget.
INCLUDING TWO UNIQUE

High-End 3D
The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.

UNIQUE SCIENTIFIC-GRADE TYPE

High-End 3D
Coronavirus atomic resolution model
Featured:



UNIQUE SCIENTIFIC-GRADE TYPE
High-end 3D
HIV Atomic Resolution Model

Featured:
Awarded:



UNIQUE SCIENTIFIC-GRADE TYPE
Main 3D

Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.
Main 3D + 2D

The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.

UNIQUE APPROACH
2D Animation
For Nature Journal

A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.
2D Animation:
For HCP and Patient Education

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Character Animation:
For HCP and Patient Education

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Deck3D

This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy. The fastest type of 3D animation to produce on the market.

UNIQUE
Pathway3D
Scientific-grade models with the fastest turnaround — delivered in days, not months


A unique combination of scientific-grade molecular simulations that accurately represents real molecular interactions and states, with all the benefits of 2D animation —affordable and fast to produce. Unbeatable quality-to-cost-per-second ratio.
UNIQUE
Clinical trial update videos
Top 20 Pharma undisclosed client, anonymized data
Animation type:
Clinical trial update
Time:
1 week
Client:
Undisclosed


Education & Impact: 500M+ views

and 100+ more


The Most Tech Enabled

75% of Tasks Automated via Algorithms, Machine Learning, and AI Agents
3D type
High-end 3D
Deck3D
2D type
Pathway3D
+20 subtypes
7-8 weeks
8-10 weeks
4-5 weeks
3-5 weeks
10 days
1-9 weeks



In-House
Studio



STRATEGY
DISCOVERY



Delivering Accuracy & Efficiency for Blexi
Production Approach
Layered Animation
Animation Mix
Modular Asset Design
We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent





We adopt a layered approach for our video animations, adding a customizable 2D layer atop the main 3D or high-end 3D visuals. This method allows for rapid repurposing of content for any event or audience, often with negligible additional costs.
A modular structure for our assets facilitates easy repurposing for different media and audiences with minimal effort. This flexibility significantly enhances each asset’s value and lifespan.
By streamlining our processes through hundreds of projects and automating outdated practices with proprietary software, we not only achieve superior quality at competitive prices, but also deliver projects up to three times faster.
We carefully select from our range of six main animation types and twenty subtypes to ensure we use the most effective and cost-efficient animation for each scene. Typically, a project might incorporate two to four different animation styles.
All fueled by the most advanced production pipeline in the industry


Flexible & Modular Approach for Blexi



Confidential — Not for Public Consumption or Distribution
Flexible and Modular Approach for Blexi
| OPTIONS | COMPLEXITY | LENGTH |
|---|---|---|
|
Option A |
High-end type The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy. |
~ 3.5 min |
|
Option B |
Main3D + 2D types The most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic combined with a relatively simple, yet still eye-catching 2D animation style |
~ 3.5 min |
|
Option C |
Main3D, Deck3D, 2D types Combines the most universal, eye-catching 2D, and Deck3D eye-catching like our main 3D, but slightly less detailed backgrounds |
~ 3.5 min |
|
Option D |
Main3D + 2D shortened version The most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic combined with a relatively simple, yet still eye-catching 2D animation style |
~ 2.5 min |
The "build your own" system provides complete transparency and flexibility in the planning phase, allowing tailoring to specific needs, audience, and budget.
Initial "chapterized" scripts and pricing for Blexi MOA provided under separate cover based on preliminary options below. Additional animation styles/options can be tailored further with additional discovery.
Short formats & Chapterized assets for Blexi

UNIQUE
Popular packages for 60-90 second MoA
BuildYourOwn™ — A Unique Pricing System

Entry Package
Solid Base
One of a Kind
Very Best of 3D
$30-45K/minute
or
$50-60K/minute
$65-80K/minute
$120-200K/minute
100%
Pathway 3D
Most Chosen by Clients
100%
2D or Patient 2D
60%
Deck 3D
40%
Main 3D
60%
Main 3D
30%
Main 3D + 2D
10%
High-end 3D
90%
High-end 3D
10%
Main 3D





* Initial "chapterized" scripts and pricing options for Blexi MOA provided under separate cover and can be tailored further.
Blexi one-pager infographic leave behind
Development of 1 infographic leave behind for multichannel use:
Hours and OOPs assume Visual Science to:
-
Development of a front back leave behind for multichannel use
-
Utilize existing JNJ Medical look/feel to develop layout
-
Content and imagery leveraged from video animation
-
Introduction to AML
-
Mutations in develpment of AML
-
KMT2A in AML
-
NMP1 in AML
-
Mennin as a druggable target in AML
-
Menin inhibitors and advantages of Bleximenib
-
-
Includes full editorial QC (copyedit, annotation and fact check) prior to each Med/Legal review
-
Client reviews assume 3 rounds of client revisions (1 round for outline review, 1 prior to submission of layout for MLR review, 1 round prior to final MLR approval). Visual Science to prepare for 2 rounds of Med/Legal submission; 1 for review for revisions; BGB to upload into Veeva for final approval
-
OOP Assumptions assume art usage rights, artist illustration, and retouching.
Price range: $25-$30k

Confidential — Not for Public Consumption or Distribution


Relevant Work Sample
Front
Back


Strategic Services for Blexi


SCIENTIFIC NARRATIVES, PLATFORMS, LEXICON DEVELOPMENT

-
A medical strategic team that has developed
100+ narratives and scientific platforms -
Expertise spanning early pipeline programs
to blockbuster therapies


Much More Than a "Scientific Platform"
01
A cross-functional strategic exercise
to define the clinical value and scientific
rationale of your molecule
02
A clear and compelling story
scalable for all external audiences
03
An internal asset that expedites
approval of external facing assets
Confidential — Not for Public Consumption or Distribution
SCIENTIFIC
PLATFORM
Medical Affairs
Commercial
Regulatory
Clinical Program
IR & Corporate Comm.
Payer/Market Access/HEOR


Scalable from Early to Late-Stage Programs
The overarching story
of your molecule and
the clinical challenge
it solves
NARRATIVE
Breaks down the narrative into 5-6 discrete topics,
such as unmet need,
MOA, and clinical
trial results
CONCEPTS
5-8 evidence driven Statements which
support each
Concept
STATEMENTS
Hyperlinked and annotated reference
that support each statement
EVIDENCE
Identifiable Evidence
Gaps Needed to Tell
Full Story of your product
GAPS
Program development:
Confidential — Not for Public Consumption or Distribution
The Visual Science Process

The VS medical team will review available evidence, and generate
the brief that summarizes
the project plan.
DEFINE THE STRATEGY
VALIDATE & ROLLOUT
VALIDATE & ROLLOUT
ANALYZE THE
LANDSCAPE
Download
Meeting
Mindset
workshop
Draft Core
Concepts
Draft Scientific Statements
Curate Scientific Evidence
Expert
Validation
Functional
Roll-out
Our team and
your internal stakeholders will workshop current audience mindsets, and ID changes
that can ease product uptake.
Informed by the mindset workshop,
VS will draft
an overarching scientific narrative and core concepts to be reviewed by the core team.
With the core concepts settled,
we draft scientific statements to support each
core concepts
and review with
the core team.
The VS team will align & annotate evidence to
agreed scientific statements.
Once evidence is finalized, it is key
to validate with
your audience.
Once finalized,
we recommend reengaging the extended team
to review and adopt.
01
The core team will align with
Visual Science and drive the effort kickoff to delivery.
02
The Visual Science team will moderate this process taking in and adjudicating perspectives.
03
Extended team includes stakeholders from all internal functions, to take
in perspectives from multiple lenses.
KOLs for veracity, community to test resonance.
Confidential — Not for Public Consumption or Distribution
Expert Insights
Deliverable
Slide set in PPT including results from audit,
high-level narrative and key data gaps
(up to 40 slides)
Scientific Platform Pricing
Workshops
Evidence
Early clinical data, Data on file (DOF),
competitive data
Current asset data, competitive
data included as bibilography
Current asset data, competitive data, fully
annoted/referenced, and key evidence gaps
Scientific Debrief only
Virtual workshop up to 2 hours and summary of key
findings in PPT (8-10 slides)
1/2 Day workshop with up to 5-7 key
company stakeholders; Summary of key
decisions in PPT (15-20 slides)
Incorporate secondary market research
and/or expert feedback captured via AdBds
or Investigators Meetings
Conduct 1-2 one-hour Expert Interviews
and incorporate feedback
Workshop with 3-5 Experts;
remote meeting up to 2 hours
Slide set in PPT including results from audit,
high-level narrative and key data gaps
(up to 15 slides)
Online Scientific Platform with access
for multiple stakeholders
Narrative/Platform
and Lexicon
Generate high-level narrative focused on unmet
needs in disease state, key differentiating features
of the asset
Narrative and Platform initiation, including
level 1 core concepts; Level 2 Scientific statements;
placeholders for key evidence needed
Full Scientific Platform including Narrative Level 1,
Scientific Statements Level 2, and Key pieces
of evidence Level 3
Asset 1
Landscape assessment, review of pre-clinical
or early stage data, competitive assesment
Landscape assessment, competitive assessment,
market research, Add summaries,
and medical download call
Landscape assessment, competitive assessment,
market research, AdBd summaries, and medical
download call; 5-7 slide summary of audit
Early Stage (Clin-P1)
Mid Stage (P1-P2)
Late Stage (P2-Pre-Launch)
PACKAGE 2
PACKAGE 3
PACKAGE 1
Timing
kickoff to delivery
8-10 weeks
4-6 Weeks
12-15 weeks
Ballpark
fees only
$80-100K
$45-65K
$120-150K


Partnering


Your Visual Science Team*

MEDICAL WRITING / STRATEGY
MEDICAL
ACCOUNT
PROJECT MGMT
CREATIVE & TECH
Sean Rooney, PhD
Chief Medical Strategy
Chief Executive Officer
Michael Russo
Head, Strategic Partnerships
Ivan K., M.Sc
Jenn Terrell, MBA
Client Services Lead
Yury Stefanov, PhD
Nancy Miller
Marianna Jain
Associate Director,
Project Management
Lori Magnelli
VP, Managomant
Supervisor
Marni Kelman. M.Sc
Rich Friel
Lori Magnelli
Associate Project
Manager
Nicole Cooper
Dan Purkis
Qais Saket
Medical Writer
Medical Writer
Medical Writer
Medical Writer
Chief Science Offer
Medical Doctor
Associate Medical
Director
Max Kulemza
Head of CG & Tech
Tobias Van Schnider
VP, IT



* All employess are full time
EXECUTIVE MANAGEMENT
Additional support resources (Editorial, Studio, Digital, Production, Presentation Services) are available to meet your needs
Alex Whitewood
VP, Creative Director
Ihor Cherno
VP, VFX
Nicole Cooper
Associate Medical
Director


Appendix


DECKS AND INFOGRAPHICS
97% of clients rate working with us 9 or 10/10


Atsena Tx. Investor deck


Type:
Series B deck
Time:
6 weeks
Scope:
IR, scientific flow optimization, design, illustrations, animations
Jasper Tx (NASDAQ: JSPR) – Corporate Deck


Type:
Corporate deck for public company
Time:
4 weeks
Scope:
Design, illustrations, animations
Hookipa (NAS: HOOK) – Corporate Deck


Type:
Corporate deck for public company
Time:
5 weeks
Scope:
Scientific flow optimization, design, illustrations, animations
3D Infographics and Illustrations



Type:
High-end 3D infographics for deck
Time:
1 week


2D Infographics and Illustrations

Type:
2D infographics for deck
Time:
1 week
MoA Illustrations for Decks



WEB & APPS
97% of clients rate working with us 9 or 10/10


APOGEE Tx: Web-site / MoA / Deck
NASDAQ: APGE


Type:
Corporate website for public company
Time:
10 weeks
Scope:
Design, development, illustrations, animations

Enveric Biosciences Web-site
NASDAQ: ENVB




Type:
Corporate website for public company
Time:
9 weeks
Scope:
Design, development, illustrations, animations
Touch Panels and Interactive Decks
For congress support and in field communications


Plain Language Summaries — Now in Visual Form


UNIQUE
POSTER AR
97% of clients rate working with us 9 or 10/10





PosterAR platform
UNIQUE


PosterAR platform
UNIQUE TECHNOLOGY
Mobile-first version of the poster
PPT slides with key takeaways
Client Testimonials
97% of clients rate working with us 9 or 10/10


High-end 3D + Pathway 3D
12 days — yes, days!


10 weeks

High-end 3D


High-end 3D
12 weeks
2D


8 weeks
High-end 3D

10 weeks
High-end 3D


10 weeks
3D


7 weeks
Main 3D


8 weeks
High-end 3D



8 weeks
High-end 3D


High-end 3D
9 weeks
3D

4 weeks
Simplified 3D

Have we piqued your interest? Let's chat.



JNJ Visual Science | June 18 25
By Visual Science
JNJ Visual Science | June 18 25
Visual Science is an award-winning biomedical visualization and animation company which brings scientists, software engineers, designers and computer graphics specialists under one roof to produce visual content and graphics that are eye-catching and scientifically rigorous. Since 2007, we’ve helped both Fortune 500 and small companies around the world share cutting-edge ideas using clear, compelling graphics. Our graphics have been featured by leading media outlets and viewed hundreds of millions of times.
- 111